Inspire Veterinary Partners Files 8-K for Material Agreement

TL;DR

Inspire Vet Partners signed a big deal, filing 8-K on 12/17/25.

AI Summary

Inspire Veterinary Partners, Inc. filed an 8-K on December 17, 2025, reporting a material definitive agreement entered into on December 12, 2025. The filing also includes financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Virginia Beach, VA.

Why It Matters

This 8-K filing indicates a significant new agreement for Inspire Veterinary Partners, which could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• December 12, 2025 (date) — Date of earliest event reported
• December 17, 2025 (date) — Date of Report
• Nevada (jurisdiction) — State of incorporation
• Virginia Beach, VA (location) — Address of principal executive offices
• (757) 734-5464 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat

Filing Documents

• ea0269985-8k_inspire.htm (8-K) — 29KB
• ea026998501ex10-1_inspire.htm (EX-10.1) — 27KB
• ex10-1_001.jpg (GRAPHIC) — 2KB
• 0001213900-25-122899.txt ( ) — 230KB
• ivp-20251212.xsd (EX-101.SCH) — 3KB
• ivp-20251212_lab.xml (EX-101.LAB) — 33KB
• ivp-20251212_pre.xml (EX-101.PRE) — 22KB
• ea0269985-8k_inspire_htm.xml (XML) — 4KB

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On December 12, 2025, Inspire Veterinary Partners, Inc. (the "Company") entered into a Consulting Agreement (the "Consulting Agreement") with 622 Capital LLC, a single member limited liability company (the "Consultant"), pursuant to which the Consultant will provide the Company with business development services related to business financing opportunities. In consideration for the services to be provided under the Consulting Agreement, the Company agreed to issue the Consultant an aggregate of 9,450,000 shares of the Company's Class A common stock, par value $0.0001 per share (the "Shares") issuable as follows: 3,300,000 Shares were issued upon execution of the Consulting Agreement and 6,150,000 Shares are issuable within five business days after the execution of the Consulting Agreement. The Shares are being issued pursuant to the Company's 2022 Equity Incentive Plan and are registered on the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission. The Consulting Agreement contains customary representations, covenants, and indemnification and confidentiality provisions and will remain in effect until terminated in accordance with its terms. The foregoing description of the Consulting Agreement is qualified in its entirety by reference to the Consulting Agreement, a copy of which is filed as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference. Item. 9.01. Financial Statements and Exhibits Exhibit No. Description 10.1 Consulting Agreement, dated December 12, 2025, between Inspire Veterinary Partners, Inc. and 622 Capital LLC. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 17, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR